(Echinococcus multilocularis)
2,737 results
  • In vitro evaluation of the efficacy of azithromycin against the larvae of Echinococcus multilocularis. [Journal Article]
    Acta Trop. 2026 Sep 23; :108335. [Online ahead of print]Liao X, Zhao J, … Lü GAT
  • Alveolar echinococcosis (AE) is a serious zoonotic parasitic disease caused by the larvae of Echinococcus multilocularis. Given the limitations of current medications, there is an urgent necessity for the development of novel pharmacological treatments for AE. Azithromycin, a macrolide antibiotic, exhibits both antibacterial and antiparasitic effects. This study aimed to investigate its effects o…
  • GHSR and TLR4 collectively promote hepatic inflammation and aberrant repair in alveolar echinococcosis. [Journal Article]
    Front Immunol. 2026; 17:1919853.Chen G, Zhou T, … Zhu JFI
  • CONCLUSIONS: Collectively, upregulated GHSR and TLR4 jointly promote Echinococcus multilocularis-associated hepatic damage via sustaining persistent inflammation and dysregulated proliferative tissue repair. This study demonstrates coordinated pro-pathological involvement of GHSR and TLR4 in AE progression and provides in vivo and proteomic evidence supporting the exploration of targeted interventions against parasitic liver disorders.
  • Comparative proteomics reveals a conserved core of tegumental proteins in parasitic flatworms. [Journal Article]
    Int J Parasitol. 2026 Sep 02; :104963. [Online ahead of print]Guarnaschelli I, Lima A, … Koziol UIJ
  • Parasitic flatworms, including cestodes and trematodes, are covered by a specialized syncytial tegument that mediates nutrient uptake and host-parasite interactions. While the tegument of trematodes has been extensively characterized, its molecular composition in cestodes remains largely unknown. In this work, we performed a comparative proteomic analysis of the tegument of three cestode species,…
  • Alveolar echinococcosis. [Review]
    Curr Opin Infect Dis. 2026 Oct 01; 39(5):387-395.Stojković M, Junghanss T, Gehling KGCO
  • CONCLUSIONS: Treatment options for alveolar echinococcosis have not changed in decades. Cure is only available for early and limited hepatic disease amenable to R0-surgical resection. Advanced disease, ineligible for surgery, is treated with benzimidazoles with a parasitostatic effect on Echinococcus multilocularis. The prognosis of alveolar echinococcosis ranges from excellent to poor depending mainly on the extent of hepatopathy induced by irreversible damage to the biliary and vascular system of the liver. Benzimidazole intolerance dramatically worsens prognosis, as parasitic growth cannot be suppressed in inoperable patients.